Arbutus to Participate in Two Upcoming Investor ConferencesGlobe Newswire • about 2 months agoWARMINSTER, Pa., March 08, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...